Stomatin-like protein-2 confers neuroprotection effect in oxygen-glucose deprivation/reoxygenation-injured neurons by regulating AMPK/Nrf2 signalling

References

• Feigin VL, Norrving B, Mensah GA. Global burden of stroke. Circ Res. 2017;120(3):439–448.
   PubMed Web of Science ®Google Scholar
• Li D, Shao Z, Vanden Hoek TL, et al. Reperfusion accelerates acute neuronal death induced by simulated ischemia. Exp Neurol. 2007;206(2):280–287.
   PubMed Web of Science ®Google Scholar
• Lansberg MG, Albers GW, Wijman CA. Symptomatic intracerebral hemorrhage following thrombolytic therapy for acute ischemic stroke: a review of the risk factors. Cerebrovasc Dis. 2007;24(1):1–10.
   PubMed Web of Science ®Google Scholar
• Ahmad N, Al-Subaiec AM, Ahmad R, et al. Brain-targeted glycyrrhizic-acid-loaded surface decorated nanoparticles for treatment of cerebral ischaemia and its toxicity assessment. Artif Cells Nanomed Biotechnol. 2019;47(1):475–490.
   PubMed Web of Science ®Google Scholar
• Ahmad N, Ahmad R, Alam MA, et al. Quantification and brain targeting of eugenol-loaded surface modified nanoparticles through intranasal route in the treatment of cerebral ischemia. Drug Res (Stuttg). 2018;68(10):584–595.
   PubMed Web of Science ®Google Scholar
• Ahmad N, Ahmad R, Naqvi AA, et al. Rutin-encapsulated chitosan nanoparticles targeted to the brain in the treatment of cerebral ischemia. Int J Biol Macromol. 2016;91:640–655.
   PubMed Web of Science ®Google Scholar
• Ahmad N, Ahmad R, Naqvi AA, et al. Intranasal delivery of quercetin-loaded mucoadhesive nanoemulsion for treatment of cerebral ischaemia. Artif Cells Nanomed Biotechnol. 2018;46(4):717–729.
   PubMed Web of Science ®Google Scholar
• Khoshnam SE, Winlow W, Farzaneh M, et al. Pathogenic mechanisms following ischemic stroke. Neurol Sci. 2017;38(7):1167–1186.
   PubMed Web of Science ®Google Scholar
• Ahmad N, Ahmad R, Abbas Naqvi A, et al. The effect of safranal loaded mucoadhesive nanoemulsion on oxidative stress markers in cerebral ischemia. Artif Cells Nanomed Biotechnol. 2017;45(4):775–787.
   PubMed Web of Science ®Google Scholar
• Ahmad N, Umar S, Ashafaq M, et al. A comparative study of PNIPAM nanoparticles of curcumin, demethoxycurcumin, and bisdemethoxycurcumin and their effects on oxidative stress markers in experimental stroke. Protoplasma. 2013;250(6):1327–1338.
   PubMed Web of Science ®Google Scholar
• Lapatsina L, Brand J, Poole K, et al. Stomatin-domain proteins. Eur J Cell Biol. 2012;91(4):240–245.
   PubMed Web of Science ®Google Scholar
• Wang Y, Morrow JS. Identification and characterization of human SLP-2, a novel homologue of stomatin (band 7.2b) present in erythrocytes and other tissues. J Biol Chem. 2000;275(11):8062–8071.
   PubMed Web of Science ®Google Scholar
• Da Cruz S, De Marchi U, Frieden M, et al. SLP-2 negatively modulates mitochondrial sodium-calcium exchange. Cell Calcium. 2010;47(1):11–18.
   PubMed Web of Science ®Google Scholar
• Christie DA, Lemke CD, Elias IM, et al. Stomatin-like protein 2 binds cardiolipin and regulates mitochondrial biogenesis and function. Mol Cell Biol. 2011;31(18):3845–3856.
   PubMed Web of Science ®Google Scholar
• Mitsopoulos P, Lapohos O, Weraarpachai W, et al. Stomatin-like protein 2 deficiency results in impaired mitochondrial translation. PLoS One. 2017;12(6):e0179967.
   PubMed Web of Science ®Google Scholar
• Cao W, Zhang B, Liu Y, et al. High-level SLP-2 expression and HER-2/neu protein expression are associated with decreased breast cancer patient survival. Am J Clin Pathol. 2007;128(3):430–436.
   PubMed Web of Science ®Google Scholar
• Chang D, Ma K, Gong M, et al. SLP-2 overexpression is associated with tumour distant metastasis and poor prognosis in pulmonary squamous cell carcinoma. Biomarkers. 2010;15(2):104–110.
   PubMed Web of Science ®Google Scholar
• Liu D, Zhang L, Shen Z, et al. Increased levels of SLP-2 correlate with poor prognosis in gastric cancer. Gastric Cancer. 2013;16(4):498–504.
   PubMed Web of Science ®Google Scholar
• Liu Z, Yang Y, Zhang Y, et al. Stomatin-like protein 2 is associated with the clinicopathological features of human papillary thyroid cancer and is regulated by TGF-beta in thyroid cancer cells. Oncol Rep. 2014;31(1):153–160.
   PubMed Web of Science ®Google Scholar
• Sun F, Ding W, He JH, et al. Stomatin-like protein 2 is overexpressed in epithelial ovarian cancer and predicts poor patient survival. BMC Cancer. 2015;15(1):746.
   PubMedGoogle Scholar
• Zhang L, Ding F, Cao W, et al. Stomatin-like protein 2 is overexpressed in cancer and involved in regulating cell growth and cell adhesion in human esophageal squamous cell carcinoma. Clin Cancer Res. 2006;12(5):1639–1646.
   PubMed Web of Science ®Google Scholar
• Cui Z, Zhang L, Hua Z, et al. Stomatin-like protein 2 is overexpressed and related to cell growth in human endometrial adenocarcinoma. Oncol Rep. 2007;17(4):829–833.
   PubMed Web of Science ®Google Scholar
• Wang Y, Cao W, Yu Z, et al. Downregulation of a mitochondria associated protein SLP-2 inhibits tumor cell motility, proliferation and enhances cell sensitivity to chemotherapeutic reagents. Cancer Biol Ther. 2009;8(17):1651–1658.
   PubMed Web of Science ®Google Scholar
• Qiu Z, Chen X, Yin L, et al. Stomatin-like protein-2 relieve myocardial ischemia/reperfusion injury by adenosine 5'-monophosphate-activated protein kinase signal pathway. J Cell Biochem. 2018;10(10):27561.
   Google Scholar
• Zanon A, Hicks AA, Pramstaller PP, et al. SLP-2: a potential new target for improving mitochondrial function in Parkinson's disease. Neural Regen Res. 2017;12(9):1435–1436.
   PubMed Web of Science ®Google Scholar
• Zanon A, Kalvakuri S, Rakovic A, et al. SLP-2 interacts with Parkin in mitochondria and prevents mitochondrial dysfunction in Parkin-deficient human iPSC-derived neurons and Drosophila. Hum Mol Genet. 2017;26(13):2412–2425.
   PubMed Web of Science ®Google Scholar
• Lee JS, Surh YJ. Nrf2 as a novel molecular target for chemoprevention. Cancer Lett. 2005;224(2):171–184.
   PubMed Web of Science ®Google Scholar
• Kobayashi M, Itoh K, Suzuki T, et al. Identification of the interactive interface and phylogenic conservation of the Nrf2-Keap1 system. Genes Cells. 2002;7(8):807–820.
   PubMed Web of Science ®Google Scholar
• Tebay LE, Robertson H, Durant ST, et al. Mechanisms of activation of the transcription factor Nrf2 by redox stressors, nutrient cues, and energy status and the pathways through which it attenuates degenerative disease. Free Radic Biol Med. 2015;88(Pt B):108–146.
   PubMed Web of Science ®Google Scholar
• Liu L, Locascio LM, Dore S. Critical role of Nrf2 in experimental ischemic stroke. Front Pharmacol. 2019;10:153.
   PubMed Web of Science ®Google Scholar
• Zhang R, Xu M, Wang Y, et al. Nrf2-a promising therapeutic target for defensing against oxidative stress in stroke. Mol Neurobiol. 2017;54(8):6006–6017.
   PubMed Web of Science ®Google Scholar
• Hu G, Zhang J, Xu F, et al. Stomatin-like protein 2 inhibits cisplatin-induced apoptosis through MEK/ERK signaling and the mitochondrial apoptosis pathway in cervical cancer cells. Cancer Sci. 2018;109(5):1357–1368.
   PubMed Web of Science ®Google Scholar
• Tondera D, Grandemange S, Jourdain A, et al. SLP-2 is required for stress-induced mitochondrial hyperfusion. EMBO J. 2009;28(11):1589–1600.
   PubMed Web of Science ®Google Scholar
• Yang CT, Li JM, Li LF, et al. Stomatin-like protein 2 regulates survivin expression in non-small cell lung cancer cells through beta-catenin signaling pathway. Cell Death Dis. 2018;9(4):425.
   PubMedGoogle Scholar
• Zhou C, Li Y, Wang G, et al. Enhanced SLP-2 promotes invasion and metastasis by regulating Wnt/beta-catenin signal pathway in colorectal cancer and predicts poor prognosis. Pathol Res Pract. 2019;215(1):57–67.
   PubMed Web of Science ®Google Scholar
• Jeon SM, Chandel NS, Hay N. AMPK regulates NADPH homeostasis to promote tumour cell survival during energy stress. Nature. 2012;485(7400):661–665.
   PubMed Web of Science ®Google Scholar
• Ren Y, Shen HM. Critical role of AMPK in redox regulation under glucose starvation. Redox Biol. 2019;25:101154.
   PubMed Web of Science ®Google Scholar
• Jiang S, Li T, Ji T, et al. AMPK: potential therapeutic target for ischemic stroke. Theranostics. 2018;8(16):4535–4551.
   PubMed Web of Science ®Google Scholar
• Sun B, Ou H, Ren F, et al. Propofol inhibited autophagy through Ca(2+)/CaMKKbeta/AMPK/mTOR pathway in OGD/R-induced neuron injury. Mol Med. 2018;24(1):58.
   PubMedGoogle Scholar
• Zhou F, Wang M, Ju J, et al. Schizandrin A protects against cerebral ischemia-reperfusion injury by suppressing inflammation and oxidative stress and regulating the AMPK/Nrf2 pathway regulation. Am J Transl Res. 2019;11(1):199–209.
   PubMed Web of Science ®Google Scholar
• Duan J, Cui J, Yang Z, et al. Neuroprotective effect of Apelin 13 on ischemic stroke by activating AMPK/GSK-3beta/Nrf2 signaling. J Neuroinflamm. 2019;16(1):24.
   PubMedGoogle Scholar